期刊
JOURNAL OF DIABETES
卷 10, 期 5, 页码 365-372出版社
WILEY
DOI: 10.1111/1753-0407.12640
关键词
diabetes; diagnosis; HbA1c
资金
- National Key R&D Program of China [2016YFC1305600, 2017YFC1310700, 2016YFC0901200, 2016YFC1304904]
- Ministry of Health [201502007]
- Ministry of Science and Technology [2015BAI12B14, 2015BAI12B02, 2017ZX09304007, 2017ZX09304007-001]
- National Natural Science Foundation of China [81621061, 81561128019, 81622011]
- Gaofeng Gaoyuan Program for Clinical Scientists from Shanghai Jiao-Tong University School of Medicine [20161301, 20161307]
- Shanghai Outstanding Academic Leader Program
- Outstanding Young Talent Program from Shanghai Municipal Government
The prevalence of diabetes is increasing markedly worldwide, especially in China. Hemoglobin A1c is an indicator of mean blood glucose concentrations and plays an important role in the assessment of glucose control and cardiovascular risk. In 2010, the American Diabetes Association included HbA1c 6.5% into the revised criteria for the diagnosis of diabetes. However, the debate as to whether HbA1c should be used to diagnose diabetes is far from being settled and there are still unanswered questions regarding the cut-off value of HbA1c for diabetes diagnosis in different populations and ethnicities. This review briefly introduces the history of HbA1c from discovery to diabetes diagnosis, key steps towards using HbA1c to diagnose diabetes, such as standardization of HbA1c measurements and controversies regarding HbA1c cut-off points, and the performance of HbA1c compared with glucose measurements in the diagnosis of diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据